Lidocaine hydrochloride

✨ ‌Lidocaine Hydrochloride (CAS 6108-05-0) | USP-Grade Local Anesthetic & Antiarrhythmic Agent‌ ✨

🧪 ‌Product Overview‌

‌Lidocaine Hydrochloride‌ (CAS 6108-05-0), also known as ‌Lignocaine HCl monohydrate‌, is a high-purity ‌amide-class local anesthetic‌ and ‌antiarrhythmic drug‌ with the molecular formula ‌C₁₄H₂₂N₂O·HCl·H₂O‌ and a molecular weight of ‌288.81‌. This white crystalline powder (≥99% purity) is widely used in clinical settings for rapid pain relief and cardiac arrhythmia management. It exhibits strong penetration, fast onset (5 minutes), and prolonged duration (1–1.5 hours), making it 2× more potent than procaine with lower toxicity.

‌Key Functions‌:

• Induces local anesthesia for surgical and diagnostic procedures.

• Stabilizes cardiac membranes to treat ventricular arrhythmias.

• Serves as a reference standard in pharmaceutical quality control.

‌Target Industries‌: Pharmaceuticals, hospitals, veterinary medicine, and research labs.

⭐ ‌Key Advantages‌

🏭 ‌Applications‌

• ‌Surgical Anesthesia‌

  : Topical creams, injectables for minor surgeries and dental procedures.

• ‌Cardiac Care‌

  : Intravenous use for ventricular tachycardia and fibrillation.

• ‌Pharmaceutical R&D‌

  : Impurity profiling and API synthesis in drug development.

📊 ‌Quality Assurance‌

• ‌Certifications‌

  : Complies with 

  ‌USP/EP‌

   pharmacopeial standards and 

  ‌ISO 9001‌

  .

• ‌Testing‌

  : Validated via HPLC, NMR, and FTIR.

• ‌Packaging‌

  : Available in 

  ‌25kg‌

   bulk drums or smaller R&D batches (10mg–1kg).

📈 ‌Market Insights‌

The global local anesthetics market is projected to grow at ‌6.1% CAGR (2025–2030)‌, driven by increasing surgical volumes and demand for non-opioid pain management. Lidocaine remains a cornerstone in emergency medicine, with ‌Asia-Pacific‌ leading adoption due to expanding healthcare infrastructure and cost-effective manufacturing.